Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online April 5, 2007
Stem Cells Vol. 25 No. 7 July 2007, pp. 1769 -1778
doi:10.1634/stemcells.2006-0385; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0385v1
25/7/1769    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hur, J.
Right arrow Articles by Kim, H.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hur, J.
Right arrow Articles by Kim, H.-S.

TISSUE-SPECIFIC STEM CELLS

Akt Is a Key Modulator of Endothelial Progenitor Cell Trafficking in Ischemic Muscle

Jin Hura, Chang-Hwan Yoona, Choon-Soo Leea, Tae-Youn Kima, Il-young Oha, Kyung-Woo Parka,b, Ji-Hyun Kima, Hyun-Sook Leea, Hyun-Jae Kanga,b, In-Ho Chaea,b, Byung-Hee Oha,b, Young-Bae Parka,b, Hyo-Soo Kima,b

aNational Research Laboratory for Cardiovascular Stem Cell, Seoul National University College of Medicine, Seoul, Korea;
bDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Korea

Key Words. Angiogenesis • Endothelial progenitor cells • Ischemia • Cell signaling • Cell adhesion molecules • Gene therapy

Correspondence: Hyo-Soo Kim, M.D., Department of Internal Medicine, Seoul National University Hospital, 28 Yongon-dong Chongno-gu, Seoul 110-744, Korea. Telephone: 82-2-2072-2226; Fax: 82-2-766-8904; e-mail: hyosoo{at}snu.ac.kr

Received June 24, 2006; accepted for publication March 26, 2007.
First published online in STEM CELLS EXPRESS   April 5, 2007.



Trafficking of transplanted endothelial progenitor cells (EPCs) to ischemic tissue is enhanced by stromal-derived factor 1 (SDF-1) and vascular endothelial growth factor (VEGF). However, it has not been studied how these cytokines modulate the local milieu to entrap EPCs. This study was performed to elucidate a molecular pathway of trafficking EPCs through Akt and to test its application as an adjuvant modality to increase EPC homing. In a mouse hind limb ischemia model, systemically administered 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine-labeled mouse EPCs showed three stages of homing to ischemic limb: adhesion to endothelial cells (ECs), incorporation to capillary, and transendothelial migration into extravascular space. As an underlying mechanism to control adhesion of EPCs to ECs, we found that Akt was activated in ECs of ischemic muscle by ischemia-induced VEGF and SDF-1. In vitro and in vivo experiments using adenoviral vector for constitutively active or dominant-negative Akt genes showed that activated Akt enhanced intercellular adhesion molecule 1 (ICAM-1) expression on ECs. Akt activation in ECs also enhanced EPC incorporation to ECs and transendothelial migration in vitro experiments. Activated Akt was sufficient for induction of EPC homing even in normal hind limb, where VEGF or SDF-1 was not increased. Finally, local Akt gene transfer to ischemic limb significantly enhanced homing of systemically administered EPCs, new vessel formation, blood flow recovery, and tissue healing. Akt plays a key role in EPC homing to ischemic limb by controlling ICAM-1 and transendothelial migration. Modulation of Akt in the target tissue may be an adjunctive measure to enhance homing of systemically administered stem cells, suggesting a possibility of cell-and-gene hybrid therapy.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
Stem CellsHome page
H. Shao, Y. Tan, D. Eton, Z. Yang, M. G. Uberti, S. Li, A. Schulick, and H. Yu
Statin and Stromal Cell-Derived Factor-1 Additively Promote Angiogenesis by Enhancement of Progenitor Cells Incorporation into New Vessels
Stem Cells, May 1, 2008; 26(5): 1376 - 1384.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I.-Y. Oh, C.-H. Yoon, J. Hur, J.-H. Kim, T.-Y. Kim, C.-S. Lee, K.-W. Park, I.-H. Chae, B.-H. Oh, Y.-B. Park, et al.
Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle
Blood, December 1, 2007; 110(12): 3891 - 3899.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2007 by AlphaMed Press.